HK1249428A1 - 預防或治療缺血/再灌注損傷之後無複流的方法 - Google Patents
預防或治療缺血/再灌注損傷之後無複流的方法Info
- Publication number
- HK1249428A1 HK1249428A1 HK18109055.3A HK18109055A HK1249428A1 HK 1249428 A1 HK1249428 A1 HK 1249428A1 HK 18109055 A HK18109055 A HK 18109055A HK 1249428 A1 HK1249428 A1 HK 1249428A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- prevention
- treatment
- methods
- reperfusion injury
- following ischemia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36312910P | 2010-07-09 | 2010-07-09 | |
US36313310P | 2010-07-09 | 2010-07-09 | |
US41265510P | 2010-11-11 | 2010-11-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1249428A1 true HK1249428A1 (zh) | 2018-11-02 |
Family
ID=45441572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18109055.3A HK1249428A1 (zh) | 2010-07-09 | 2018-07-12 | 預防或治療缺血/再灌注損傷之後無複流的方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US9345738B2 (zh) |
EP (3) | EP3539554A1 (zh) |
JP (5) | JP6319738B2 (zh) |
CN (4) | CN103249423A (zh) |
CA (1) | CA2804404C (zh) |
HK (1) | HK1249428A1 (zh) |
WO (1) | WO2012006569A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015509500A (ja) * | 2012-02-22 | 2015-03-30 | ステルス ペプチドズ インターナショナル インコーポレイテッド | 眼疾患を予防または治療するための方法および組成物 |
DK2830644T3 (en) * | 2012-03-30 | 2017-02-27 | Stealth Peptides Int Inc | Methods and Preparations for the Prevention and Treatment of Neuropathy |
CA2912386A1 (en) * | 2013-05-14 | 2014-11-20 | Stealth Biotherapeutics Corp | Methods for the prevention or treatment of left ventricular remodeling |
CA2916492A1 (en) * | 2013-06-27 | 2014-12-31 | Stealth Biotherapeutics Corp | Peptide therapeutics and methods for using same |
JP2019523260A (ja) | 2016-04-11 | 2019-08-22 | カーノット, エルエルシー | キラルペプチド |
US11034724B2 (en) | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
RS64128B1 (sr) * | 2017-12-15 | 2023-05-31 | Stealth Biotherapeutics Inc | Peptidi sa ciljanim delovanjem na mitohondrije |
US11795196B2 (en) | 2017-12-15 | 2023-10-24 | Stealth Biotherapeutics Inc. | Mitochondria-targeting peptides |
US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
ES2964535T3 (es) * | 2018-09-21 | 2024-04-08 | Corflow Therapeutics Ag | Aparato para la evaluación de la disfunción microvascular |
WO2020189593A1 (ja) | 2019-03-20 | 2020-09-24 | 三菱ケミカル株式会社 | 重合体、分離剤、重合体の製造方法、化合物の分離方法及び化合物の製造方法 |
RU2711414C1 (ru) * | 2019-03-27 | 2020-01-17 | Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) | Способ прогнозирования асимптомного повреждения вещества головного мозга при ангиореконструктивных операциях на сонных артериях |
BR112022001123A2 (pt) | 2019-07-24 | 2022-03-15 | Stealth Biotherapeutics Inc | O composto peptidomimétido (r)-2-amino-n-((s-l-(((s)-5-aminol-(3-benzil-1,2,4,-oxadiazol5-il)pentil)amino-3-(4-hidroxi-2,6-dimetilfenil)-1-oxopropan-2-il)-5-guanidinopentanamida no tratamento de doenças neurodegenerativas |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5182106A (en) | 1986-05-15 | 1993-01-26 | Emory University | Method for treating hypothermia |
US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
JPH05301868A (ja) | 1992-04-23 | 1993-11-16 | Mitsui Toatsu Chem Inc | 虚血性心疾患治療剤 |
US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
CA2480427C (en) | 2002-08-01 | 2010-08-31 | Yamanouchi Pharmaceutical Co., Ltd. | Novel potassium-dependent sodium-calcium exchanger |
EP3479838A1 (en) * | 2003-02-04 | 2019-05-08 | Cornell Research Foundation, Inc. | Uses of aromatic-cationic peptide |
AU2005208821B8 (en) * | 2003-02-04 | 2010-10-14 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
WO2007035640A2 (en) * | 2005-09-16 | 2007-03-29 | Cornell Research Foundation, Inc. | Methods for reducing cd36 expression |
AU2010339410A1 (en) * | 2009-12-31 | 2012-07-19 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of vessel occlusion injury |
EP2915540A1 (en) * | 2009-12-31 | 2015-09-09 | Stealth Peptides International, Inc. | Methods for performing a coronary artery bypass graft procedure |
EP3210615A1 (en) * | 2010-03-15 | 2017-08-30 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
-
2011
- 2011-07-08 WO PCT/US2011/043424 patent/WO2012006569A1/en active Application Filing
- 2011-07-08 CN CN2011800429365A patent/CN103249423A/zh active Pending
- 2011-07-08 US US13/808,027 patent/US9345738B2/en active Active
- 2011-07-08 CN CN201510122649.5A patent/CN105879008A/zh not_active Withdrawn
- 2011-07-08 CN CN201710574500.XA patent/CN107569675A/zh active Pending
- 2011-07-08 CA CA2804404A patent/CA2804404C/en active Active
- 2011-07-08 CN CN201610616831.0A patent/CN106620645A/zh active Pending
- 2011-07-08 JP JP2013518868A patent/JP6319738B2/ja active Active
- 2011-07-08 EP EP19157391.4A patent/EP3539554A1/en not_active Withdrawn
- 2011-07-08 EP EP11804436.1A patent/EP2590664B1/en active Active
- 2011-07-08 EP EP23185558.6A patent/EP4285994A3/en active Pending
-
2016
- 2016-05-18 US US15/158,005 patent/US10322159B2/en active Active
- 2016-07-08 JP JP2016136149A patent/JP2016172781A/ja active Pending
-
2018
- 2018-07-12 HK HK18109055.3A patent/HK1249428A1/zh unknown
-
2019
- 2019-01-04 JP JP2019000305A patent/JP2019052188A/ja active Pending
-
2020
- 2020-04-30 JP JP2020080135A patent/JP2020114880A/ja active Pending
-
2021
- 2021-11-08 JP JP2021181839A patent/JP2022012924A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US10322159B2 (en) | 2019-06-18 |
EP4285994A3 (en) | 2024-01-17 |
EP4285994A2 (en) | 2023-12-06 |
JP2019052188A (ja) | 2019-04-04 |
EP2590664B1 (en) | 2019-03-27 |
JP2016172781A (ja) | 2016-09-29 |
WO2012006569A1 (en) | 2012-01-12 |
EP3539554A1 (en) | 2019-09-18 |
JP2013531682A (ja) | 2013-08-08 |
JP6319738B2 (ja) | 2018-05-09 |
CN106620645A (zh) | 2017-05-10 |
EP2590664A1 (en) | 2013-05-15 |
CA2804404C (en) | 2020-10-20 |
CN105879008A (zh) | 2016-08-24 |
US20170087204A1 (en) | 2017-03-30 |
JP2022012924A (ja) | 2022-01-17 |
CN103249423A (zh) | 2013-08-14 |
EP2590664A4 (en) | 2014-01-15 |
JP2020114880A (ja) | 2020-07-30 |
CA2804404A1 (en) | 2012-01-12 |
CN107569675A (zh) | 2018-01-12 |
US9345738B2 (en) | 2016-05-24 |
US20130196921A1 (en) | 2013-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1249428A1 (zh) | 預防或治療缺血/再灌注損傷之後無複流的方法 | |
IL262611A (en) | Treatment for lipodystrophy | |
PT2470168T (pt) | Métodos para a prevenção e o tratamento de isquemia cerebral | |
EP2875824A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF CACHEXIA | |
HK1210085A1 (zh) | 用於水淨化的方法和裝置 | |
EP2861627A4 (en) | PROCESS FOR INCREASING THE EXTRACTIBLE RUBBER CONTENT OF NON-HEVEA PLANT MATERIAL | |
HRP20181950T1 (hr) | Samidorfan (alks 33) u kombinaciji s buprenorfinom za liječenje depresivnih poremećaja | |
HK1209424A1 (zh) | 用於治療再灌注損傷的氧雜二環庚烷和氧雜二環庚烯 | |
SG2014014724A (en) | METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS | |
HK1199616A1 (zh) | 惡病質治療 | |
AP2015008338A0 (en) | Compounds for the treatment and prevention of retroviral infections | |
EP2878302A4 (en) | COMPOSITION FOR PREVENTING OR TREATING OSTEOARTHRITIS | |
EP2536436A4 (en) | ANTIMIR-451 FOR THE TREATMENT OF POLYCYTHEMICS | |
EP2744502A4 (en) | METHODS USEFUL IN PREVENTING HYPOXIC INJURY | |
EP2616485A4 (en) | STEPPED DEVELOPED PEPTIDE FOR THE TREATMENT OF BRAIN INJURIES | |
HK1201181A1 (zh) | 用於治療和預防病毒感染的新型環孢菌素衍生物 | |
ZA201408058B (en) | Compositions and methods for the treatment of epilepsy | |
EP2675448A4 (en) | METHOD FOR TREATING ISCHEMIA / REPERFUSION INJURIES | |
PL2872131T3 (pl) | Oleaceina do leczenia lub zapobiegania chorobom będących następstwem blaszki miażdżycowej | |
EP2588146A4 (en) | TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS BY L-METHYLFOLATE | |
GB201219696D0 (en) | Agents for the prevention and/or treatment of central nervous system damamge | |
GB201221362D0 (en) | Inhibiting the decomposition of acidulants | |
GB201221197D0 (en) | Inhibiting the decomposition of acidulants | |
HUP1200221A2 (en) | Sludge treatment | |
PL120341U1 (pl) | Zespól do powierzchniowej obróbki wlewków aluminium |